Evidence map›Paper›PMID 37523360›Full record

ArticlePloS one2023

Cohort profile: The Corona Behavioral Unit cohort, a longitudinal mixed-methods study on COVID-19-related behavior, well-being and policy support in the Netherlands.

Wijnand van den Boom, Mart van Dijk, Bianca Snijders, Guus Luijben, Jan van der Laan, Saskia Euser, Jet G Sanders, Anne H Buitenhuis, Pita Spruijt, Floor Kroese and 10 more

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Wijnand van den BoomNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.ORCID 0000-0001-5981-7689
Mart van DijkNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Bianca SnijdersNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Guus LuijbenNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.ORCID 0000-0001-7183-1846
Jan van der LaanNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Saskia EuserNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Jet G SandersNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Anne H BuitenhuisNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Pita SpruijtNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Floor KroeseNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Mattijs LambooijNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Yvette MuhrenNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Nannah TakGGD GHOR Nederland, Utrecht, The Netherlands.
Koen van der SwaluwNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Caroline van RossumNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Thijs NielenNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Janneke ElberseNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Reint Jan RenesAmsterdam University of Applied Sciences, Amsterdam, The Netherlands.
Mariken LeursNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Marijn de BruinNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This 'cohort profile' aims to provide a description of the study design, methodology, and baseline characteristics of the participants in the Corona Behavioral Unit cohort. This cohort was established in response to the COVID-19 pandemic by the Dutch National Institute for Public Health and the Environment (RIVM) and the regional public health services. The aim was to investigate adherence of and support for COVID-19 prevention measures, psychosocial determinants of COVID-19 behaviors, well-being, COVID-19 vaccination, and media use. The cohort also examined specific motivations and beliefs, such as for vaccination, which were collected through either closed-ended items or open text responses. In April 2020, 89,943 participants aged 16 years and older were recruited from existing nation-wide panels. Between May 2020 and September 2022, 99,676 additional participants were recruited through online social media platforms and mailing lists of higher education organizations. Participants who consented were initially invited every three weeks (5 rounds), then every six weeks (13 rounds), and since the summer of 2022 every 12 weeks (3 rounds). To date, 66% of participants were female, 30% were 39 years and younger, and 54% completed two or more questionnaires, with an average of 9.2 (SD = 5.7) questionnaires. The Corona Behavioral Unit COVID-19 cohort has published detailed insights into longitudinal patterns of COVID-19 related behaviors, support of COVID-19 preventive measures, as well as peoples' mental wellbeing in relation to the stringency of these measures. The results have informed COVID-19 policy making and pandemic communication in the Netherlands throughout the COVID-19 pandemic. The cohort data will continuously be used to examine COVID-19 related outcomes for scientific analyses, as well as to inform future pandemic preparedness plans.

Indexed as

COVID-19COVID-19 VaccinesFemaleHumansMaleNetherlandsPandemicsPolicySARS-CoV-2COVID-19 Vaccines

Identifiers

PMID37523360
PMCPMC10389736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.